Pasithea Therapeutics Corp Cash Flow-to-Debt Ratio
Pasithea Therapeutics Corp cash flow-to-debt ratio. Pasithea Therapeutics Corp (KTTA) has a Cash Flow-to-Debt Ratio of -2.03x as of September 2025, meaning its operating cash flow of $-2.89 Million could theoretically repay -2% of its total liabilities ($1.42 Million) in one year. Check how high is Pasithea Therapeutics Corp's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pasithea Therapeutics Corp (2020–2024)
Cash flow-to-debt ratio of Pasithea Therapeutics Corp from 2020 to 2024. Historical debt coverage capacity for Pasithea Therapeutics Corp across 5 annual periods. Also explore KTTA year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Pasithea Therapeutics Corp Cash Flow-to-Debt Ratio by Year (2020–2024)
Pasithea Therapeutics Corp cash flow-to-debt ratio by year from 2020 to 2024. Year-by-year debt coverage analysis for Pasithea Therapeutics Corp. For the full cash flow conversion analysis, see Pasithea Therapeutics Corp (KTTA) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -10.86x | $-13.92 Million | $1.28 Million | ▼ -119.9% |
| 2023 | -4.94x | $-13.43 Million | $2.72 Million | ▲ +3.3% |
| 2022 | -5.11x | $-13.69 Million | $2.68 Million | ▼ -205.6% |
| 2021 | -1.67x | $-3.17 Million | $1.90 Million | ▲ +71.5% |
| 2020 | -5.86x | $-38.69K | $6.60K | — |